Finder makes money from featured partners, but editorial opinions are our own.

How to buy Healius (HLS) shares in Australia

Learn how to easily invest in Healius shares.

Healius is a diagnostics & research business based in Australia. Healius shares (HLS) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Healius has a trailing 12-month revenue of around $1.7 billion. If you're looking to buy shares, check out the steps below.

How to buy shares in Healius

To buy shares listed in Australia such as Healius, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.

  1. Open and fund your brokerage account.
    Complete an application with your personal and financial details, including your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  2. Search for Healius.
    Find the share by name or ticker symbol: HLS. Research its history to confirm it's a solid investment against your financial goals.
  3. Purchase now or later.
    Buy today with a market order or use a limit order to delay your purchase until Healius reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
  4. Decide on how many to buy.
    At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  5. Check on your investment.
    Congratulations, you own a part of Healius. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.

Healius stock price (ASX:HLS)

Use our graph to track the performance of HLS stocks over time.

Healius shares at a glance

Information last updated 2024-06-14.
52-week range$1.08 - $2.9989
50-day moving average $1.2691
200-day moving average $1.528
Target price$1.26
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.65

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Asset class
Finder AwardExclusive
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
CFD service. Capital at risk.
Join the world's biggest social trading network when you trade stocks, commodities and currencies from the one account.
Moomoo Share Trading
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get $100 to trade when you deposit $1,000, or $200 when you deposit $5,000 or more. Earn 6.8% p.a. on uninvested cash. T&Cs apply.
Trade shares on the ASX, the US markets and buy ETFs with Moomoo. Plus join a community over 20 million investors.
Tiger Brokers
Tiger Brokers
ASX shares, Global shares, US shares, ETFs
Finder exclusive: 10 no-brokerage US or ASX market trades in the first 180 days + 7% p.a. on uninvested cash with first deposit of any amount, plus US$30 TSLA + US$30 NVDA shares with deposits up to AU$2000. T&Cs apply.
Trade Australian, US and Asian stocks with no minimum deposit on Tiger Broker’s feature-packed platform.
CMC Invest
Finder Award
CMC Invest
ASX shares, Global shares, Options trading, US shares, ETFs
$0 brokerage on US, UK, Canadian and Japanese markets (FX spreads apply).
Trade over 45,000 shares and ETFs from Australia and 15 major global markets. Plus, buy Aussie shares or ETFs for $0 brokerage up to $1,000 (First buy order of each security, each day - excludes margin loan settled trades).
ASX shares, Global shares, Options trading, US shares, ETFs
Get advanced research and trading tools with $0 brokerage and free lvl 2 NASDAQ stock data for 30 days. T&Cs apply.
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.
Saxo Invested
ASX shares, Global shares, Options trading, US shares, ETFs
Access 22,000+ stocks on 50+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.

Is it a good time to buy Healius stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Healius price performance over time

Historical closes compared with the last close of A$1.42

1 week (2024-06-06) 3.27%
1 month (2024-05-16) 11.37%
3 months (2024-03-15) 12.70%
6 months (2023-12-15) -5.96%
1 year (2023-06-16) -54.34%
2 years (2022-06-16) -61.62%
3 years (2021-06-16) -67.36%
5 years (2019-06-14) -55.06%

Is Healius under- or over-valued?

Valuing Healius stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Healius's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Healius's EBITDA

Healius's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $107.2 million (£0.0 million).

The EBITDA is a measure of a Healius's overall financial performance and is widely used to measure stock profitability.

Healius financials

Revenue TTM $1.7 billion
Operating margin TTM 1.85%
Gross profit TTM $554.3 million
Return on assets TTM 1.31%
Return on equity TTM -68.02%
Profit margin -57.63%
Book value 1.447
Market capitalisation $1 billion

TTM: trailing 12 months

Healius share dividends

We're not expecting Healius to pay a dividend over the next 12 months.

Have Healius's shares ever split?

Healius's shares were split on a 511:493 basis on 21 August 2018. So if you had owned 493 shares the day before the split, the next day you would own 511 shares. This wouldn't directly have changed the overall worth of your Healius shares – just the quantity. However, indirectly, the new 3.5% lower share price could have impacted the market appetite for Healius shares which in turn could have impacted Healius's share price.

Healius share price volatility

Over the last 12 months, Healius's shares have ranged in value from as little as $1.08 up to $2.9989. A popular way to gauge a stock's volatility is its "beta".

HLS.AU volatility(beta: 0.7)Avg. volatility(beta: 1.00)LowHigh

Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Healius's is 0.698. This would suggest that Healius's shares are less volatile than average (for this exchange).

Healius overview

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Healius in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask a Question

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms Of Service and Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site